Picture of Cabbacis logo

CABI Cabbacis Share Price

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+116.43%
3mn/a
6mn/a
1yrn/a
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-16.67%
50d MA+11.23%
200d MA+11.23%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-31.34%
Return on Equity-60.5%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Cabbacis EPS forecast chart

Profile Summary

Cabbacis Inc. focuses on its proprietary iBlend reduced-nicotine cigarettes and vaporizer pods in development and to secure Food and Drug Administration (FDA) authorization to sell its products in the United States through the Premarket Tobacco Product Application (PMTA) process. The Company, through its wholly owned subsidiary Cabbacis LLC, operates as a federally licensed, tobacco product manufacturer and plant biotechnology company developing and commercializing consumer acceptable Modified Risk Tobacco Products (MRTPs). It has not commercialized its products which it is developing under the iBlend brand name, and its primary focus is the development of cigarettes with blends of reduced-nicotine tobacco containing about 95 percent less nicotine than that of United States brands and very-low THC cannabis, (commonly known as hemp), which is not intoxicating since it contains less than 0.3 percent THC. The Company is also developing pods for oral electronic vaporizers.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    June 30th, 2024
    Incorporated
    July 7th, 2023
    Public Since
    November 1st, 2024
    No. of Employees
    3
    Sector
    Food & Tobacco
    Industry
    Consumer Defensives
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    7,900,000
    Blurred out image of a map
    Address
    3193 Buffalo Avenue, Unit 1, NIAGARA FALLS, 14303
    Web
    Phone
    Auditors
    Prager Metis CPAs LLC

    CABI Share Price Performance

    Similar to CABI

    Picture of Adia Nutrition logo

    Adia Nutrition

    us flag iconPink Sheets on Nasdaq

    Picture of African Agriculture Holdings logo

    African Agriculture Holdings

    us flag iconPink Sheets on Nasdaq

    Picture of Agri-Dynamics logo

    Agri-Dynamics

    us flag iconPink Sheets on Nasdaq

    Picture of Agristar logo

    Agristar

    us flag iconPink Sheets on Nasdaq

    Picture of Aifarm logo

    Aifarm

    us flag iconPink Sheets on Nasdaq

    FAQ